Evidence map›Paper›PMID 42900584›Full record

ArticleThe Journal of cell biology2026

ClC-7 links PIKfyve inhibition to Rab-dependent LRRK2 activity at lysosomes.

Devin Clegg, Amanda Bentley-DeSousa, Agnes Roczniak-Ferguson, Shawn M Ferguson

Abstract read
In one paragraph

Article in The Journal of cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Devin CleggDepartments of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-9522-168X
Amanda Bentley-DeSousaDepartments of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-3667-4029
Agnes Roczniak-FergusonDepartments of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-0838-2157
Shawn M FergusonDepartments of Cell Biology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-3092-7718

Funding

Molecular mechanisms that match lysosome function to cellular demandR01GM105718 · NIGMS · YALE UNIVERSITY · PI FERGUSON, SHAWN · 2013 to 2022
$2.9M
Aligning Science Across Parkinson's disease ASAP-000580Aligning Science Across Parkinson's disease ASAP-025173Michael J. Fox Foundation for Parkinson's ResearchNIGMS NIH HHS R01 GM105718NIH HHS GM105718
6 · The paper itself

Abstract

Increased activity of leucine-rich repeat kinase 2 (LRRK2) confers Parkinson's disease risk. LRRK2 dynamically localizes to lysosomal membranes in response to various stresses, yet the mechanisms by which distinct lysosomal perturbations are communicated to LRRK2 remain unclear. Here, we show that inhibition of the lysosomal lipid kinase PIKfyve promotes LRRK2 recruitment and signaling through a pathway that requires the lysosomal chloride/proton antiporter ClC-7. ClC-7 in turn controls the accumulation of multiple Rab GTPases on lysosomes. LRRK2 signaling under these conditions requires its established Rab-binding surfaces, with Rab12 contributing significantly to this response. This pathway operates independently of CASM. In contrast, lysosomal stresses that induce CASM require both Rab-binding sites on LRRK2 and GABARAP for robust LRRK2 signaling. These findings identify ClC-7-dependent lysosomal remodeling and Rab accumulation as key features linking PIKfyve inhibition to LRRK2 signaling and reveal that distinct lysosomal stresses engage different combinations of Rab and GABARAP inputs to activate LRRK2.

Indexed as

Chloride ChannelsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LysosomesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Serine-Threonine Kinasesrab GTP-Binding ProteinsAdaptor Proteins, Signal TransducingAnimalsHEK293 CellsHumansSignal TransductionAdaptor Proteins, Signal TransducingChloride ChannelsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPIKFYVE protein, humanProtein Serine-Threonine Kinasesrab GTP-Binding Proteins

Identifiers

PMID42900584
PMCPMC13682606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.